Acetazolamide, high altitude, and plasma volume study
Treatments studied
Part of Lungs & breathing clinical trials.
This trial tests how acetazolamide affects your body's fluid levels at high altitude. It might help understand if the drug can prevent altitude sickness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 44 years old and do not smoke.
- You are generally healthy and don't take any regular medications, including birth control pills.
- Your body mass index (BMI) is between 18 and 30.
- You were born, raised, and currently live at an elevation below 1000 meters.
- If you are a woman of childbearing age, you have regular menstrual cycles and are not pregnant or nursing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using a special breathing device that creates positive pressure can help prevent acute mountain sickness (symptoms like headache, nausea, and dizziness at high altitude). It is for healthy, experienced climbers planning an expedition on Mount Aconcagua.
This study compares how well people sleep when they live at very high altitudes (above 2600 meters) compared to at sea level. By participating, you'll help researchers learn how high-altitude living affects sleep and breathing during the night.
This study looks at how your heart rate changes as you travel from high altitude (2850 meters) down to sea level and back up again. It aims to understand how healthy people's heart rhythm adapts to altitude changes, which might help in future care for those with heart or lung issues.
This trial tests whether a medicine called acetazolamide (used for altitude sickness) can help people with type 1 diabetes. It compares how your body responds while on the drug versus a placebo, using a crossover design so everyone gets both treatments.
This trial tests whether a migraine medication (Fremanezumab) can help prevent acute mountain sickness when going to high altitude. If it works, it might make high-altitude trips safer and more comfortable for healthy people.
This study tests whether adding acetazolamide or metolazone to standard treatment helps remove extra fluid better in people hospitalized for heart failure. It aims to find a safer and more effective option for managing fluid overload.
Hear when a new High Altitude Effects trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.